European Medical Solutions (ALEMS.BR)
- Previous Close
4.85 - Open
5.00 - Bid --
- Ask --
- Day's Range
5.00 - 5.50 - 52 Week Range
0.84 - 13.02 - Volume
533 - Avg. Volume
161 - Market Cap (intraday)
23.275M - Beta (5Y Monthly) 0.62
- PE Ratio (TTM)
-- - EPS (TTM)
-0.28 - Earnings Date Jul 16, 2025 - Jul 21, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
European Medical Solutions engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium. It offers R/F solutions, including PLATINUM NEO, a smart solution that revolutionizes the R/F workflow, as well as OPTIMA dRF, a robust solution; bone densitometry and body composition analysis equipment; chest and bone rooms, such as floor and ceiling tube stands; ambulatory radiography equipment; retrofit kits; C-ARM mobile operating room solutions; and mammography solutions. The company was formerly known as DMS Imaging SA and changed its name to European Medical Solutions in June 2024. DMS Imaging SA was founded in 1979 and is headquartered in Ixelles, Belgium. European Medical Solutions operates as a subsidiary of Diagnostic Medical Systems S.A.
www.dms-imaging.comRecent News: ALEMS.BR
View MorePerformance Overview: ALEMS.BR
Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is BEL 20 (^BFX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALEMS.BR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALEMS.BR
View MoreValuation Measures
Market Cap
23.28M
Enterprise Value
38.68M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.56
Price/Book (mrq)
2.29
Enterprise Value/Revenue
0.93
Enterprise Value/EBITDA
22.44
Financial Highlights
Profitability and Income Statement
Profit Margin
1.14%
Return on Assets (ttm)
1.70%
Return on Equity (ttm)
5.40%
Revenue (ttm)
47.91M
Net Income Avi to Common (ttm)
546k
Diluted EPS (ttm)
-0.28
Balance Sheet and Cash Flow
Total Cash (mrq)
4.58M
Total Debt/Equity (mrq)
191.98%
Levered Free Cash Flow (ttm)
-3.45M